ACCESS II mHealth Intervention for Human Immunodeficiency Virus (HIV) Infection

Phase-Based Progress Estimates
Human Immunodeficiency Virus (HIV) InfectionACCESS II mHealth Intervention - Behavioral
18 - 29
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether connecting with a trained peer health coach via videoconferencing can help improve ART adherence and HIV-viral load in Black and Hispanic HIV-infected adolescents and young adults, compared to those who only have access to a web-based HIV ART adherence education.

Treatment Effectiveness

Study Objectives

3 Primary · 8 Secondary · Reporting Duration: Baseline, 12 weeks, 24 weeks

3 Days
Self-reported ART adherence
Week 24
Adherence self-efficacy
Change in Anxiety
Change in Depression
Change in HIV stigma
Change in Knowledge about ART
Change in Psychological Distress
Change in Social support and isolation
Change in Substance use
Change in serum HIV RNA quantitative viral load
Client Satisfaction and Ease of Use of web-based platform

Trial Safety

Trial Design

2 Treatment Groups

HIV-infected youth: control
1 of 2
HIV-infected youth: Intervention
1 of 2

Active Control

Experimental Treatment

120 Total Participants · 2 Treatment Groups

Primary Treatment: ACCESS II mHealth Intervention · No Placebo Group · N/A

HIV-infected youth: Intervention
Experimental Group · 1 Intervention: ACCESS II mHealth Intervention · Intervention Types: Behavioral
HIV-infected youth: control
ActiveComparator Group · 1 Intervention: ACCESS II control condition · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 12 weeks, 24 weeks

Who is running the clinical trial?

Jacobi Medical CenterOTHER
21 Previous Clinical Trials
3,617 Total Patients Enrolled
NYU Langone HealthLead Sponsor
1,263 Previous Clinical Trials
753,477 Total Patients Enrolled
Ann-Margaret Navarra, PhD, CPNP-PCPrincipal InvestigatorNYU Meyers College of Nursing

Eligibility Criteria

Age 18 - 29 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have detectable HIV viral load.
You have no neuro-cognitive deficits which would impede participation in videoconferencing sessions or completion of study measure.